Skin usefulness evaluation test using test substance combination preparations - Skin usefulness evaluation test using test substance combination preparations

DRC Co., Ltd.0 sites30 target enrollmentJanuary 22, 2024

ConditionsHealthy adult female

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy adult female
Sponsor: DRC Co., Ltd.
Enrollment: 30
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

January 22, 2024

End Date

May 16, 2024

Last Updated

2 years ago

Study Type

Interventional

Sex

Female

Investigators

Sponsor

DRC Co., Ltd.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\. Subjects who have urticaria, inflammation, eczema, trauma, acne, pimples, warts, blemishes, etc. or their traces on the evaluation site 2\. Subjects with a history or current history of atopic dermatitis, or with atopic predisposition 3\. Subjects who have received cosmetic treatment at the evaluation site or plan to receive it during the study period 4\. Subjects who use creams, gels, all\-in\-one products, beauty devices, packs or oils on the evaluation site 5\. Subjects who continuously use drugs, health foods, supplements, skin care products, cosmetics, quasi\-drugs that advocate efficacy related to the efficacy examined in this study 6\. Subjects who have performed the following within the past 4 weeks or plan to do so during the study period a) Changed or started health foods, basic cosmetics or sunscreen agents used on the evaluation sites b) Exposed to ultraviolet rays beyond daily life c) Participated in other human trials d) Received a special skin care treatment on the evaluation site 7\. Subjects who work night shifts or day and night shifts 8\. Subjects who are undergoing treatment at medical institutions for the treatment or prevention of disease, or those who are judged to require treatment 9\. Subjects with a history of serious diseases of sugar metabolism, lipid metabolism, liver function, renal function, heart, circulatory system, respiratory system, endocrine system, immune system, nervous system, alcohol or drug dependence. 10\. Subjects who are at risk of developing cosmetic or food allergies 11\. Subjects who are pregnant, breastfeeding, or wish to become pregnant during the study period 12\. Subjects who are judged by the principal investigator to be unsuitable for study participation 13\. Subjects who have significantly different wrinkle grade scores between the left and right corners of the eyes